Clinical Trial Detail

NCT ID NCT03752138
Title TK216 and Decitabine in Treating Patients With Relapsed and Refractory Acute Myeloid Leukemia
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

acute myeloid leukemia

Therapies

Decitabine + TK216

TK216

Age Groups: senior adult

No variant requirements are available.